JPS6366291B2 - - Google Patents
Info
- Publication number
- JPS6366291B2 JPS6366291B2 JP55151130A JP15113080A JPS6366291B2 JP S6366291 B2 JPS6366291 B2 JP S6366291B2 JP 55151130 A JP55151130 A JP 55151130A JP 15113080 A JP15113080 A JP 15113080A JP S6366291 B2 JPS6366291 B2 JP S6366291B2
- Authority
- JP
- Japan
- Prior art keywords
- oil
- medicine
- hair
- herbal medicine
- chinese herbal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003921 oil Substances 0.000 claims description 25
- 235000019198 oils Nutrition 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 10
- 241000411851 herbal medicine Species 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 239000002674 ointment Substances 0.000 claims description 9
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 4
- 235000012424 soybean oil Nutrition 0.000 claims description 4
- 239000003549 soybean oil Substances 0.000 claims description 4
- 208000014617 hemorrhoid Diseases 0.000 claims description 3
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 2
- 230000000903 blocking effect Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 150000001805 chlorine compounds Chemical group 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 235000002639 sodium chloride Nutrition 0.000 description 9
- 239000003925 fat Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 241000270666 Testudines Species 0.000 description 5
- 238000009835 boiling Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 241001071795 Gentiana Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- -1 analgesic Substances 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000004936 left thumb Anatomy 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241000975357 Salangichthys microdon Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 229910052571 earthenware Inorganic materials 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 210000001255 hallux Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 210000001260 vocal cord Anatomy 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
【発明の詳細な説明】
本発明は種々の病気に対して卓効を有する漢方
薬の製造方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing Chinese herbal medicines that are highly effective against various diseases.
本発明に係る漢方薬の起源は、西歴1300年頃と
古く、九州黒田家の制殿薬として伝わる一子相伝
の家伝薬であり、あ可亀油として井上家に代々引
き継がれてきたものである。井上家は関東大震災
の折、このあ可亀油約2トンを皇室に献上、卓効
あるものとして大正天皇妃殿下より感謝状と赤十
字勲章を授与された。 The origin of the Chinese herbal medicine according to the present invention dates back to around 1300 AD, and it is a family medicine handed down from one child to another as a medicine for the Kuroda family in Kyushu, and it has been passed down from generation to generation in the Inoue family as Akakame oil. . At the time of the Great Kanto Earthquake, the Inoue family presented approximately 2 tons of this Akagame oil to the Imperial Family, and was awarded a letter of appreciation and the Order of the Red Cross by Her Imperial Highness the Emperor Taisho as it was highly effective.
あ可亀油は植物油に人毛を加熱溶解させて得ら
れる液状およびペースト状漢方薬であり、火傷、
外傷、皮膚病、殺菌、止痒、鎮痛、解熱、止血、
痔疾、婦人病等に卓効ありとして古くから多くの
愛用者を有するものである。また大正8年には同
あ可亀油液剤を「女の薬」として命名し、婦人病
一般の治療薬として製造許可を得、昭和20年3月
大阪空襲による罹災まで全国に100軒以上の特約
販売店を有していた。またあ可亀油の製造法は一
子相伝のものであり、その製造法は極秘に保持さ
れて今日に到つている。 Akakame oil is a liquid or paste herbal medicine obtained by heating and dissolving human hair in vegetable oil.
Trauma, skin disease, sterilization, antipruritic, analgesic, antipyretic, hemostasis,
It has been used by many people since ancient times as it is said to be extremely effective in treating hemorrhoids, women's diseases, etc. In 1919, the same Kagame oil solution was named "Women's Medicine" and obtained permission to manufacture it as a treatment for general gynecological diseases. It had special dealers. Furthermore, the method for producing Akakame oil was passed down from generation to generation, and the method has been kept strictly confidential to this day.
しかしながら、古来、伝承されてきたあ可亀油
の製造法には多くの秘法ないし骨があり、それを
十分に修得しない場合は均一かつ卓効のある製品
を得難く、万人の容易に製造し得るものではな
い。 However, there are many secret methods and secrets to the manufacturing method of red turtle oil that have been passed down since ancient times, and if these methods are not fully mastered, it will be difficult to obtain a uniform and highly effective product, and it will not be possible for everyone to easily manufacture it. It's not possible.
本発明者(あ可亀油製造法の承継者)は、あ可
亀油の製造工程で少量の無機塩を用いることによ
り従来のあ可亀油に匹敵する薬効を維持しなが
ら、かつ製品ロツトのばらつきのないあ可亀油を
容易に製造し得ることを見出し、本発明を完成し
た。 The present inventor (successor of the method for producing Aka turtle oil) has discovered that by using a small amount of inorganic salt in the production process of Aka turtle oil, it is possible to maintain medicinal efficacy comparable to that of conventional Aka turtle oil while reducing product lot production. The present invention was completed based on the discovery that it is possible to easily produce Aka turtle oil with no variation in color.
即ち、本発明は無機塩の存在下、実質上空気を
遮断した状態で毛髪を油脂中に加熱溶解させるこ
とを特徴とする漢方薬の製造法に関する。 That is, the present invention relates to a method for producing a Chinese herbal medicine, which comprises heating and dissolving hair in oil and fat in the presence of an inorganic salt while substantially blocking air.
本発明に用いる毛髪は人の頭髪、特に黒髪が好
ましく、これを洗剤を用いて十分に洗浄する。好
ましくは沸盪水中に約5分間煮沸し殺菌した後、
塵のかからないようにした約1週間間から10日間
日光にさらす。 The hair used in the present invention is preferably human hair, particularly black hair, which is thoroughly washed with a detergent. After sterilization, preferably by boiling in boiling water for about 5 minutes,
Leave it exposed to sunlight for about a week to 10 days without getting dusty.
毛髪の使用量は油脂1000mlに対し150g〜230
g、、好ましくは180g〜210gである。 The amount used for hair is 150g to 230g per 1000ml of oil and fat.
g, preferably 180 g to 210 g.
本発明に用いる油脂は植物油、特に沸点の高い
ものが好ましい。これは、毛髪を溶解する際、比
較的高い温度で長時間の処理が必要とされるた
め、これに耐え得る性能が要請されるためであ
る。好ましい油脂としては大豆油、しらしめ油、
綿実油、ごま油、サフラワー油、ぬか油等である
が大豆油なたね油、綿実油および特に大豆やなた
ねのしらしめ油において好結果が得られる。 The fats and oils used in the present invention are preferably vegetable oils, particularly those with a high boiling point. This is because when hair is dissolved, treatment at a relatively high temperature for a long time is required, and performance that can withstand this is required. Preferred fats and oils include soybean oil, shashime oil,
Cottonseed oil, sesame oil, safflower oil, rice bran oil, etc., but good results are obtained with soybean oil, rapeseed oil, cottonseed oil, and especially soybean and rapeseed whitebait oil.
油脂に毛髪を溶解する際の温度は200℃以上、
好ましくは300℃以上、特に約350℃で、実質上、
空気の遮断された状態で行なう。溶解は通常30分
〜2時間好ましくは40分〜1時間かけて行ない、
液量が最初の仕込み油量とほぼ同量になるまで行
なう。 The temperature when dissolving hair in oil is over 200℃,
Preferably above 300°C, especially about 350°C, substantially
Do this in an air-tight environment. Dissolution is usually carried out over a period of 30 minutes to 2 hours, preferably 40 minutes to 1 hour,
Continue until the amount of liquid is approximately the same as the amount of oil initially added.
実質上空気の遮断された状態とは例えば蒸気孔
を有する土瓶に蓋をする程度のものでよく、窒素
雰囲気下での処理でもよい。要するに油脂類の発
火や急激な熱分解の生じない条件であればよく、
完全な密封状態での処理を意味するものではな
い。 The state in which air is substantially shut off may be, for example, a state in which a lid is placed on an earthenware pot having a steam vent, or processing may be performed under a nitrogen atmosphere. In short, it is sufficient that the conditions do not cause ignition or rapid thermal decomposition of oils and fats.
This does not mean processing in a completely sealed state.
本発明において、油脂類には少量の無機塩を添
加する。無機塩の添加は毛髪の油脂への溶解性を
促進し、毛髪、油脂、反応条件管理等による製品
のばらつきを少なくする。添加量は油脂1000mlに
対し0.1〜1.8g、より好ましくは0.3g〜1gであ
る。 In the present invention, a small amount of inorganic salt is added to the fats and oils. Addition of inorganic salts promotes the solubility of hair in oils and fats, and reduces product variations due to hair, oils, reaction condition control, etc. The amount added is 0.1 to 1.8 g, more preferably 0.3 g to 1 g per 1000 ml of oil or fat.
好ましい無機塩は中性塩、例えば食塩、塩化カ
リウム、塩化カルシウム、塩化マグネシウム、り
ん酸ナトリウム、りん酸カリウム等のりん酸塩、
などがある。特に好ましくは塩化ナトリウムまた
はそれを主成分とするものである。これらの塩
は、単独で用いても混合してもよい。 Preferred inorganic salts are neutral salts, such as common salt, phosphates such as potassium chloride, calcium chloride, magnesium chloride, sodium phosphate, potassium phosphate, etc.
and so on. Particularly preferred is sodium chloride or one containing sodium chloride as a main component. These salts may be used alone or in combination.
以上のごとく処理した液成分は約200℃以下に
さまして過し、得られた液はそのまま液剤と
するか、常套の方法、例えばメリケン粉やヘツト
等で錬つて軟膏とする。 The liquid components treated as described above are cooled to below about 200°C, and the resulting liquid is used as a liquid preparation as it is, or it is made into an ointment by kneading it in a conventional manner, for example, with American flour or hetsuto.
さらに過残渣は、すり鉢等で擂り潰し、ゲン
チアナ末等と混じて粉末とする。 Further, the excess residue is crushed in a mortar or the like and mixed with gentian powder etc. to form a powder.
液剤は主として痔薬、耳、鼻、咽喉等の塗布
薬、婦人病薬、練剤は皮膚病、火傷、外傷、目薬
等に、粉剤は胃腸薬(整腸、急性および慢性胃腸
病)食あたり、十二脂腸潰瘍、肝炎、肝硬変、胆
石、糖尿病、甲状腺腫等に有効である。 Liquid formulations are mainly used for hemorrhoids, liniments for ears, nose, throat, etc., and gynecological medicines. Powder formulations are used for skin diseases, burns, trauma, eye drops, etc., and powder formulations are used for gastrointestinal medicine (intestinal regulation, acute and chronic gastrointestinal diseases), and with meals. It is effective for duodenal ulcer, hepatitis, liver cirrhosis, gallstones, diabetes, goiter, etc.
以下実施例をあげて本発明を説する。 The present invention will be explained below with reference to Examples.
実施例 1
(液剤)
人の黒色毛髪をシヤンプーで十分に洗浄し、熱
湯で5分間煮沸する。これをほぐして約1週間日
光に曝らし、完全に乾燥させる。Example 1 (Liquid) Human black hair was thoroughly washed with shampoo and boiled in boiling water for 5 minutes. This is loosened and exposed to sunlight for about a week to completely dry.
別の大豆油1800mlを小さな蒸気孔のある蓋のつ
いた容器に採り、これに前記処理済みの毛髪350
gおよび自然食塩1gを加え、ガスの強火で350
℃、約1時間加熱する。毛髪が完全に溶解した
後、200℃に冷まし、目の細かいトオシで過す
る。液を常温に冷却すると濃褐色の特異臭のあ
る液状成分1800mlが得られた。この液剤中の主要
アミノ酸はグルタミン酸(13.3%)、シスチン
(13.3%)、ロイシン(10.0%)、アルギニン、セ
リン、プロリン、グリシン、アスパラギン酸、チ
ロシン、バリン、アラニン、フエニルアラニン、
スレオニン、リジン、メチオニン、ヒスチジン、
ロイシン等が検出された。 Add another 1800 ml of soybean oil to a lidded container with a small steam vent and add 350 ml of the treated hair.
Add 1g of salt and 1g of natural salt, and heat to 350 ml over high heat.
℃ for about 1 hour. After the hair is completely dissolved, it is cooled to 200℃ and passed through a fine toothpick. When the liquid was cooled to room temperature, 1800 ml of a dark brown liquid component with a characteristic odor was obtained. The main amino acids in this solution are glutamic acid (13.3%), cystine (13.3%), leucine (10.0%), arginine, serine, proline, glycine, aspartic acid, tyrosine, valine, alanine, phenylalanine,
threonine, lysine, methionine, histidine,
Leucine etc. were detected.
実施例 2
ヘツト(硬化牛脂)1Kgを約200℃でとかした
後、一旦、100℃に冷ます。これにメリケン粉
(強力粉)600gを加え乳状にし、次いで実施例1
と同様にして得た液剤1800mlを加えて、撹拌しな
がら10℃で約20分間加熱する。上層の泡を掬い取
つた後、火かり降ろして過し冷却するとバター
状の濃褐色の軟膏が得られた。Example 2 1 kg of hardened beef tallow is melted at about 200°C and then cooled to 100°C. Add 600g of Meriken flour (strong flour) to this to make it milky, and then Example 1
Add 1,800 ml of the solution obtained in the same manner as above, and heat at 10°C for about 20 minutes while stirring. After scooping out the foam from the upper layer, the mixture was removed from the heat, filtered, and cooled to yield a buttery, dark brown ointment.
実施例 3
実施例1と同様にして得られる過残渣を砕
き、すり鉢でとろとろになるまで擂り漬す。その
100gにゲンチアナ末100gを加え、さらに擂り漬
し、やゝ苦味のある黒色粉末が得られた。Example 3 The excess residue obtained in the same manner as in Example 1 is crushed and pickled in a mortar until it becomes mushy. the
100 g of gentian powder was added to 100 g, and the mixture was further pickled to obtain a black powder with a slightly bitter taste.
本発明方法によつて製造した漢方薬を用いた病
気の治癒例を以下に示す。 Examples of cures for diseases using Chinese herbal medicines produced by the method of the present invention are shown below.
治癒例 1
(外傷)
(男性74才:広島)
切断中の鉄板がとんでのど仏に当る。急救車で
病院に運ばれ手術を受ける。運良く癒つても音帯
の異常は残ると診断される。Healing case 1 (Trauma) (Male, 74 years old, Hiroshima) The iron plate that was being cut hit the Buddha's throat. He was taken to the hospital by emergency ambulance and underwent surgery. Even if he was lucky enough to recover, he was diagnosed with a residual abnormality in his vocal cords.
5目目:入院中のまま医師の許可を得て本発明の
軟膏薬を脱脂綿につけ貼布。Fifth eye: Apply the ointment of the present invention to absorbent cotton and apply it with permission from the doctor while still in the hospital.
7日目:強引に退院し、以降、本発明軟膏を毎日
患部に貼布。7th day: The patient was forcibly discharged from the hospital, and from then on, the ointment of the present invention was applied to the affected area every day.
2週間目:発声が普通に戻り、のど仏は引込む。2nd week: Speech returns to normal and the throat becomes retracted.
治癒例 2
(やけど)
(女性68才:大阪)
天婦羅油で左目下目尻より頬、鼻下にかけ第2
度の火傷を負う。本発明液剤を脱脂綿に浸して貼
布、1分後に取替え痛み薄らぐ、2時間後、軟膏
を脱脂綿にのばしてて貼る。2日目、皮膚表面の
びらんをはさみで切り取り、以降1日3度薬をを
り替る。Healing case 2 (Burn) (Female 68 years old, Osaka) Apply tempura oil from the lower corner of the left eye to the cheek and under the nose.
Suffers severe burns. The solution of the present invention is soaked in absorbent cotton and applied, replaced after 1 minute to relieve the pain, and after 2 hours, the ointment is spread on absorbent cotton and applied. On the second day, cut out the sores on the skin surface with scissors, and then change the medicine three times a day.
5日目:うすく化膿 7目目:膿とれてピンク色になる。Day 5: Faint suppuration 7th eye: The pus comes out and turns pink.
8日目:色素沈着 9日目以降:1日1度、本発明軟膏をすり込む。Day 8: Pigmentation After the 9th day: Rub in the ointment of the present invention once a day.
1ケ月目:沈着色素うすくなる。1st month: Deposited pigment becomes lighter.
8ケ月目:こん跡全くなし。完治
治癒例 3
(リウマチ関節炎)
18才女性、リウマチとは知らず、本発明軟膏を
使用。薬を貼つている間痛み全くなし。2ケ月継
続使用後、左足拇指関節、右足甲中央の骨が突起
する。3ケ月後、右足甲の骨が引込み、左足拇指
関節変形して治癒。8th month: No trace at all. Completely cured case 3 (Rheumatoid arthritis) An 18-year-old female used the ointment of the present invention without knowing that she had rheumatoid arthritis. There was no pain at all while the medicine was applied. After 2 months of continuous use, the bones in the left thumb joint and the center of the right foot protrude. Three months later, the bone in the right foot retracted and the left thumb joint deformed and healed.
治癒例 4
(リウマチ)
女子中学生:足拇指関節、くるぶし、左手親脂
1関節など発赤、腫張、患部に熱と痛みあり、大
阪福島厚生年金病院にて小児リウマチで根治に2
〜3年を要すると診断される。Cured Case 4 (Rheumatism) Female junior high school student: There was redness and swelling in the big toe joints, ankles, and one joint on the left hand, as well as fever and pain in the affected areas.She was diagnosed with pediatric rheumatism at Osaka Fukushima Kosei Pension Hospital and was cured.
It is diagnosed that it will take ~3 years.
本発明軟膏を患部に塗布し、粉末薬を1日2度
服用を続けた。 The ointment of the present invention was applied to the affected area, and the powdered medicine was continued to be taken twice a day.
3日目:病院にて血液検査の結果入院をすすめら
れる。3rd day: As a result of a blood test at the hospital, hospitalization is recommended.
4日目:患部の発赤がおさまり、痛みとれる。4th day: The redness of the affected area subsides and the pain subsides.
6日目:足の腫れ引く。Day 6: Swelling in legs goes down.
8日目:血液検査の結果、入院の要なし。8th day: Blood test results show no need for hospitalization.
2週間目:完治。2nd week: Complete recovery.
Claims (1)
で毛髪を油脂中に加熱溶解させることを特徴とす
る漢方薬の製造法。 2 油脂が大豆油またはなたね油である第1項記
載の方法。 3 無機塩がナトリウム、カリウム、マグネシウ
ム、カルシウムからなる群より選ばれた金属の塩
化物である第1項記載の方法。 4 油脂1000mlに対し毛髪180〜210gおよび無機
塩0.3〜1gを用いる第1項記載の方法。 5 加熱温度が約350℃である第1項記載の方法。 6 漢方薬が液剤である第1項記載の方法。 7 漢方薬が軟膏である第1項記載の方法。 8 漢方薬が痔薬である第1項記載の方法。 9 漢方薬が火傷薬である第1項記載の方法。[Scope of Claims] 1. A method for producing a Chinese herbal medicine, which comprises heating and dissolving hair in oil and fat in the presence of an inorganic salt while substantially blocking air. 2. The method according to item 1, wherein the fat or oil is soybean oil or rapeseed oil. 3. The method according to item 1, wherein the inorganic salt is a chloride of a metal selected from the group consisting of sodium, potassium, magnesium, and calcium. 4. The method according to item 1, using 180 to 210 g of hair and 0.3 to 1 g of inorganic salt per 1000 ml of oil. 5. The method according to item 1, wherein the heating temperature is about 350°C. 6. The method according to paragraph 1, wherein the Chinese herbal medicine is a liquid preparation. 7. The method according to paragraph 1, wherein the Chinese herbal medicine is an ointment. 8. The method according to paragraph 1, wherein the Chinese herbal medicine is a hemorrhoid medicine. 9. The method according to paragraph 1, wherein the herbal medicine is a burn medicine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15113080A JPS5775925A (en) | 1980-10-27 | 1980-10-27 | Production of kind of chenese medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15113080A JPS5775925A (en) | 1980-10-27 | 1980-10-27 | Production of kind of chenese medicine |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5775925A JPS5775925A (en) | 1982-05-12 |
JPS6366291B2 true JPS6366291B2 (en) | 1988-12-20 |
Family
ID=15512015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP15113080A Granted JPS5775925A (en) | 1980-10-27 | 1980-10-27 | Production of kind of chenese medicine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5775925A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020050686A (en) * | 2000-12-21 | 2002-06-27 | 김기종 | Burn Womd Topical agent |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5589212A (en) * | 1978-12-28 | 1980-07-05 | Yahachi Funatsu | Preparation of active constituent for hair conditioner and cosmetic cream |
-
1980
- 1980-10-27 JP JP15113080A patent/JPS5775925A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5589212A (en) * | 1978-12-28 | 1980-07-05 | Yahachi Funatsu | Preparation of active constituent for hair conditioner and cosmetic cream |
Also Published As
Publication number | Publication date |
---|---|
JPS5775925A (en) | 1982-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH02207023A (en) | Herb drug extract, its preparation and use thereof | |
CN110215465A (en) | A kind of leech processes formula and technique | |
JPS6366291B2 (en) | ||
CN105012750A (en) | Traditional Chinese medicine alcohol for external injury and pain relief | |
CN107412491A (en) | A kind of externally applied ointment for treating hyperosteogeny patch and preparation method thereof | |
CN107802814A (en) | Chinese medicine composition and its manufactured plaster and preparation method | |
CN106880647B (en) | Baijiang Dan and its preparation method | |
CN102274342A (en) | External sticking plaster | |
KR101058072B1 (en) | Vegetable burn remedies | |
CN101612380A (en) | A kind of Chinese medicine composition for the treatment of chilblain and preparation method thereof | |
CN108210548A (en) | Chinese medicine ointment for traumatic surface and preparation method thereof | |
CN108704073A (en) | Dispel spot, mole, wart, tumor, wart Chinese medicine composition and preparation method | |
JP3534470B2 (en) | Method for producing bath or massage agent | |
CN103585334A (en) | Compound diaper ointment | |
JPH10139677A (en) | Skin lotion | |
JP2889921B2 (en) | Manufacturing method of granular foods from umeboshi, soy sauce and dandelion dried roots | |
CN1199667C (en) | Ointment for treating burns and scalds and preparation method thereof | |
CN110251635A (en) | A kind of black plaster and preparation method thereof | |
CN1294967C (en) | Externally applied plaster for treating hypertension | |
CN111514267A (en) | A Chinese medicinal composition for treating traumatic injury, sprain, and joint swelling and pain | |
JPH0427209B2 (en) | ||
KR20000055751A (en) | Aaaaa | |
CN104189193B (en) | Tinea pedis and manus Traditional Chinese medicine medicated bath and preparation method | |
CN107335031A (en) | Externally-used pain-relieving cream | |
CN117414395A (en) | Traditional Chinese medicine composition for improving gastrointestinal function and regulating intestinal flora |